DNAJB9
Basic information
Region (hg38): 7:108569867-108574850
Previous symbols: [ "MDG1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNAJB9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 1 | 1 |
Variants in DNAJB9
This is a list of pathogenic ClinVar variants found in the DNAJB9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-108571745-A-G | not specified | Likely benign (Jul 11, 2022) | ||
7-108571751-A-G | not specified | Uncertain significance (Aug 12, 2021) | ||
7-108571799-A-G | not specified | Uncertain significance (Nov 11, 2024) | ||
7-108571849-A-C | not specified | Uncertain significance (Mar 25, 2024) | ||
7-108571854-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
7-108571859-G-A | not specified | Uncertain significance (Nov 10, 2024) | ||
7-108571873-G-C | not specified | Uncertain significance (Mar 01, 2024) | ||
7-108571914-C-T | not specified | Uncertain significance (Feb 01, 2023) | ||
7-108572910-C-T | not specified | Uncertain significance (May 31, 2022) | ||
7-108572920-C-A | not specified | Uncertain significance (Apr 24, 2023) | ||
7-108572925-A-G | not specified | Uncertain significance (Oct 03, 2022) | ||
7-108572944-C-G | not specified | Uncertain significance (Dec 17, 2021) | ||
7-108572967-A-C | not specified | Uncertain significance (May 28, 2024) | ||
7-108573047-T-G | not specified | Uncertain significance (Jun 24, 2022) | ||
7-108573081-A-G | not specified | Uncertain significance (Jun 24, 2022) | ||
7-108573088-G-A | Benign (Jun 29, 2018) | |||
7-108573218-T-G | not specified | Uncertain significance (Jan 29, 2024) | ||
7-108573269-T-G | not specified | Uncertain significance (Aug 21, 2023) | ||
7-108573346-G-T | not specified | Uncertain significance (Apr 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNAJB9 | protein_coding | protein_coding | ENST00000249356 | 2 | 5283 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.365 | 0.624 | 125725 | 0 | 18 | 125743 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.456 | 131 | 117 | 1.12 | 0.00000566 | 1503 |
Missense in Polyphen | 39 | 43.084 | 0.90522 | 538 | ||
Synonymous | -0.0917 | 39 | 38.3 | 1.02 | 0.00000173 | 385 |
Loss of Function | 2.15 | 2 | 8.93 | 0.224 | 5.73e-7 | 104 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000272 | 0.000271 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.000164 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Co-chaperone for Hsp70 protein HSPA5/BiP that acts as a key repressor of the ERN1/IRE1-mediated unfolded protein response (UPR) (By similarity). J domain-containing co-chaperones stimulate the ATPase activity of Hsp70 proteins and are required for efficient substrate recognition by Hsp70 proteins (PubMed:18400946). In the unstressed endoplasmic reticulum, interacts with the luminal region of ERN1/IRE1 and selectively recruits HSPA5/BiP: HSPA5/BiP disrupts the dimerization of the active ERN1/IRE1 luminal region, thereby inactivating ERN1/IRE1 (By similarity). Also involved in endoplasmic reticulum-associated degradation (ERAD) of misfolded proteins. Required for survival of B-cell progenitors and normal antibody production (By similarity). {ECO:0000250|UniProtKB:G3H0N9, ECO:0000250|UniProtKB:Q9QYI6, ECO:0000269|PubMed:18400946}.;
- Pathway
- XBP1(S) activates chaperone genes;Photodynamic therapy-induced unfolded protein response;VEGFA-VEGFR2 Signaling Pathway
(Consensus)
Recessive Scores
- pRec
- 0.0998
Intolerance Scores
- loftool
- 0.520
- rvis_EVS
- 0.19
- rvis_percentile_EVS
- 66.82
Haploinsufficiency Scores
- pHI
- 0.0881
- hipred
- N
- hipred_score
- 0.290
- ghis
- 0.446
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.888
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnajb9
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- immunoglobulin production;B cell differentiation;ubiquitin-dependent ERAD pathway;response to endoplasmic reticulum stress;IRE1-mediated unfolded protein response;negative regulation of IRE1-mediated unfolded protein response
- Cellular component
- nucleolus;cytoplasm;endoplasmic reticulum;endoplasmic reticulum lumen;endoplasmic reticulum membrane;extracellular exosome
- Molecular function
- protein binding;Hsp70 protein binding;chaperone binding;misfolded protein binding